Ocular inserts-Advancement in therapy of eye diseases

Journal of Advanced Pharmaceutical Technology and Research

Volumn 1, Issue 3, 2010, Pages 291-296

  Kumari, Anita ^a   Sharma, Pramod K ^a   Garg, Vipin K ^a   Garg, Garima ^a  

^a MEERUT INSTITUTE OF ENGINEERING AND TECHNOLOGY   (India)

Author keywords

Bioerosion; diffusion; membrane; ocular inserts

Indexed keywords

HYDROXYPROPYLCELLULOSE; PILOCARPINE;

AQUEOUS SOLUTION; DRUG ABSORPTION; DRUG ADMINISTRATION ROUTE; DRUG CONTAMINATION; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; EROSION; EYE DISEASE; GEL; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TEMPERATURE; MICROBIAL GROWTH; MOISTURE; NONHUMAN; OCULAR INSERTS; OSMOSIS; PH; PRIORITY JOURNAL; REVIEW; SOFT CONTACT LENS;

EID: 79952959367     PISSN: 22314040     EISSN: 09762094     Source Type: Journal    
DOI: 10.4103/0110-5558.72419     Document Type: Review

References (38)

1. Katz IM. Shaped ophthalmic inserts for treating dry eyes syndrome. US Patent 1982;4:343-787.
2. Cohen EM, Grim WM, Harwood RJ, Mehta GN. Solid state ophthalmic medication. US Patent 1979;4:179-597.
3. Chrai SS, Robinson JR. Ocular evaluation of methylcellulose vehicle in albino rabbits. J Pharm Sci 1974;63:1218-23.
4. Chrai SS, Makoid MC, Erikson SP, Robinson JR. Drop size and initial dosing frequency problems of topically applied ophthalmic drugs. J Pharm Sci 1974;64:333-8.
5. Zaki I, Fitzgerald P, Hardy JG, Wilson CG. Comparison of effect of viscosity on the precorneal residence of solution in rabbit and man. J Pharm Pharmacol 1986;38:463-6. (Pubitemid 16081897)
6. Lee VH, Robinson JF. Review: Topical ocular drug delivery; recent developments and future challenges. J Ocul Pharmacol 1976;2:67.
7. Saettone MF, Salminen L. Ocular inserts for topical delivery. Adv Drug Del Rev 1995;16:95-106.
8. Schoenwald RD. Ocular Pharmacokinetics/Pharmacodynamics. In: Mitra AK, editor. Ophthalmic drug delivery systems. New York: Marcel Dekker; 1993.
9. Davis JL, Gilger BC, Robinson MR. Novel approaches to ocular drug delivery. Curr Opin Mol Ther 2004;6:195-205.
10. Neefe CW. Contact lens for ocular drug delivery. US Patent 1974;3:786-812.
11. Gibaldi M, Perrier D. Pharmacokinetics. 2 nd ed. New York: Marcel Dekker, Inc.; 1993.
12. Robinson JC. Ocular Anatomy and Physiology Relevant to Ocular Drug Delivery. In: Mitra AK, editor. Ophthalmic drug delivery systems. New York: Marcel Dekker; 1993.
13. Chien YW. Novel drug delivery systems. 2 nd ed. New York: Marcel Dekker, Inc.; 1992.
14. Khar RK, Vyas SP. Targeted and controlled drug delivery novel carrier systems. 1 st ed. New Delhi: C.B.S. Publishers and Distributors, Inc.; 2002.
15. Mainardes RM, Urban MC, Cinto PO, Chaud MV. Colloidal carriers for ophthalmic drug delivery. Curr Drug Targets 2005;6:363-71. (Pubitemid 40667801)
16. Friedrich SW, Saville BA, Cheng YL, Rootman DS. Pharmacokinetic differences betweenocular inserts and eyedrops. J Ocul Pharmacol Ther 1996;12:5-18. (Pubitemid 26068312)
17. Michaels AS, Guilloid MS. Osmotic bursting drug delivery device. US Patent 1979;4:177-256.
18. Gurtler F, Gurny R. Patent literature review of ophthalmic inserts. Drug Dev Ind Pharm 1995;21:1.
19. Bloomfield SE, Miyata T, Dunn MW, Bueser N, Stenzel KH, Rubin AL. Soluble gentamacin ophthalmic inserts as a delivery system. Arch Opthalmol 1978;96:885-7. (Pubitemid 8314569)
20. Ahmed I, Gokhale RD, Shah MV, Patton TF. Physicochemical determinants of drug diffusion across the conjunctiva, sclera and cornea. J Pharm Sci 1987;76:583-6. (Pubitemid 18026341)
21. Eller MG, Schoenwald RD, Dixson JA, Segarra T, Barfknecht CF. Optimization models for corneal penetration of ethoxyzolamide analogues. J Pharm Sci1985;74:155-60.
22. Huang HS, Schoenwald RD, Lac JL. Corneal penetration behavior of b blocking agents II. J Pharm Sci 1983;72:1272-9.
23. Grass GM, Robinson JR. Mechanisms of corneal drug penetration II: Ultra structural analysis of potential pathways for drug movements. J Pharm Sci 1988;77:15-23. (Pubitemid 18035626)
24. Alvarez-Lorenzo C, Hiratani H. Soft contact lenses capable of sustained delivery of timolol. J Pharm Sci 2002;91:2182-92.
25. Patton TF, Robinson JR. Quantitative precorneal disposition of topically applied pilocarpine nitrate in rabbit eye. J Pharm Sci 1976;65:1295-301.
26. Himmelstein KJ, Guvenir I, Palton TP. Preliminary Pharmacokinetics model of pilocarpine uptake and distribution in the eye. J Pharm Sci1978;67:603-6. (Pubitemid 8364954)
27. Mitra AK. Opthalmic drug delivery. In: Tyle P, editor. Drug Delivery Devices. New York: Marcel Dekker; 1998.
28. Jain NK. Controlled and novel drug delivery. New Delhi: C.B.S. Publisher and distributer, Inc.; 2004.
29. Korsmeyer RW, Peppas NA. Macromolecular and modeling aspects of swelling-controlled systems. In: Roseman TJ, Mansdorf SZ, editor. Controlled Release Delivery Systems. New York: Marcel Dekker; 1983.
30. Darougar S. Patent literature review of ocular inserts. US Patent 1999;6:264-971.
31. Sahane NK, Banarjee SK, Gaikwad DD, Jadhav SL, Throat RM. Ocular Inserts-A Review. Drug Inven Tod 2010;2:57-64.
32. Rall TW. Drug used in the treatment of asthma. In: Goodman GA, editor. Goodman and Gilman's the Pharmacological Basis of Therapeutics. 9 th ed. New York: Palmer Taylor Maxwell Macmillan pergamon Publishing Corporation; 1990.
33. Insel PA. Anlgesic-antiphyretic and anti-inflammatory agents and drugs employed in the treatment of Gout. In: Goodman GA, editor. Goodman and Gilman's the Pharmacological Basis of Therapeutics. 9 th ed. New York: McGraw-Hill Health profession divisions; 1996.
34. Brogden RN, Heel RC, Pakes GE, Speight TM, Avery GS. Diclofenac sodium: A review of its pharmacological properties and therapeutics use in rheumatic diseases and pain of varying origin. Drugs 1980;20:48.
35. Lee VH, Li SY, Sasaki H, Saettone MF, Chetoni P. Influence of drug release rate on systemic timolol absorption from polymeric ocular inserts in the pigmented rabbit. J Ocul Pharmacol 1994;10:421-9. (Pubitemid 24186562)
36. Grass GM, Cobby J, Makoid MC. Ocular Delivery of pilocarpine from erodible matrices. J Pharm Sci 1984;73:618-21 (Pubitemid 14105925)
37. Govenment of India Ministry of health and family welfare. Indian Pharmacopoeia. Delhi: Controller of Publication; 1996.
38. Hughes PM, Mitra AK. Overview of ocular drug delivery and Iatrogenic ocular cytopathologies In: Mitra AK, editor. Ophthalmic Drug Delivery Systems. New York: Marcel Dekker; 1993.